Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM)

Clinica Chimica Acta

Volumn 412, Issue 5-6, 2011, Pages 455-459

  Mei, Joanne V ^a   Li, LiXia ^a   Rasmussen, Sonja A ^b   Collier, Sarah ^c   Frias, Jaime L ^b,d   Honein, Margaret A ^b   Shaw, Gary M ^e   Lorey, Fred ^f   Meyer, Robert ^g   Chaing, Shu ^g   Canfield, Mark A ^h   Jones, Jeffrey ^c   Hannon, W Harry ^a,d  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d McKing Consulting Corporation   (United States)

^e STANFORD UNIVERSITY   (United States)

^f CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^g North Carolina Division of Public Health   (United States)

^h TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

Congenital hydrocephalus; Dried blood spots; Newborn screening; Storage conditions; Toxoplasma gondii IgM

Indexed keywords

CITRULLINE; IMMUNOGLOBULIN M; LEUCINE; METHIONINE; PHENYLALANINE; THYROTROPIN; TYROSINE; VALINE;

ARTICLE; BIRTH DEFECT; BLOOD SAMPLING; BLOOD STORAGE; CONGENITAL HYDROCEPHALUS; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; GEOGRAPHY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; NONHUMAN; PRIORITY JOURNAL; STORAGE TEMPERATURE; TOXOPLASMA GONDII; UNITED STATES;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; HUMANS; HYDROCEPHALUS; IMMUNOGLOBULIN M; INFANT, NEWBORN; SENSITIVITY AND SPECIFICITY; TOXOPLASMA;

TOXOPLASMA GONDII;

EID: 78650894686     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.11.028     Document Type: Article

References (28)

1. Therrell B.L., Hannon W.H., Pass K.A., et al. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med 1996, 57:116-124.
2. Olney R.S., Moore C.A., Ojodu J.A., Lindegren M.L., Hannon W.H. Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr 2006, 148:618-622.
3. McEwen J.E., Reilly P.R. Stored Guthrie cards as DNA "banks". Am J Hum Genet 1994, 55:196-200.
4. Nørgaard-Pedersen B., Simonsen H. Biological specimen banks in neonatal screening. Acta Pediatr Suppl 1999, 432:106-109.
5. Hannon W.H., Lewis D.S., Jones W.K., Powell M.K. A quality assurance program for human immunodeficiency virus seropositivity screening of dried-blood spot specimens. Infect Control Hosp Epidemiol 1989, 10:8-13.
6. Neto E.C., Rubin R., Schulte J., Giugliani R. Newborn screening for congenital infectious diseases. Emerg Infect Dis 2004, 10:1069-1073.
7. Nelson J.A.E., Loftis A.M., Kamwendo D., et al. Nevirapine resistance in HIV-1+ infants determined using dried blood spots stored for up to 6years at room temperature. J Clin Microbiol 2009, 47:1209-1211.
8. Olshan A. Meeting report: the use of newborn blood spots in environmental research: opportunities and challenges. Environ Health Perspect 2007, 115:1767-1769.
9. Spliethoff H., Tao L., Shaver S. Use of newborn screening program blood spots for exposure assessment: declining levels of perfluorinated compounds in New York State infants. Environ Sci Technol 2008, 42:5361-5367.
10. Eyles D., Anderson C., Ko P., et al. A sensitive LC/MS/MS assay of 25OH vitamin D(3) and 25OH vitamin D(2) in dried blood spots. Clin Chim Acta 2009, 403:145-151.
11. Nielsen S.S., Mueller B.A., DeRoos A.J., Checkoway H. Newborn screening archives as a specimen source for epidemiologic studies: feasibility and potential for bias. Ann Epidemiol 2008, 18:58-64.
12. Cordovado S.K., Earley M.C., Hendrix M., et al. Assessment of DNA contamination from dried blood spots and determination of DNA yield and function using archival newborn dried blood spots. Clin Chim Acta 2009, 402:107-113.
13. Sørensen T., Spenter J., Jaliashvili I., Christiansen M., Nørgaard-Pedersen B., Petersen E. Automated time-resolved immunofluorometric assay for Toxoplasma gondii-specific IgM and IgA antibodies: study of more than 130 000 filter-paper blood-spot samples from newborns. Clin Chem 2002, 48:1981-1986.
14. Kankaanpää P, Else-Maj Suolinna and Jan Østrup. Toxoplasma gondii IgM immunoassay for neonatal screening of congenital toxoplasmosis. Available at: accessed 14 September 2010. http://las.perkinelmer.com/Content/RelatedMaterials/Posters/PST_NeonatalCongenitalToxoplasmosis.pdf.
15. Zhou Y.T., Mei J., Hannon W.H. Preparation of dried blood spots for a pilot toxoplasmosis proficiency testing program. Proceedings of the 2005 Newborn Screening and Genetics Testing Symposium, October 24-27, Portland, OR 2005.
16. Proficiency Testing Program for anti-Toxoplasma gondii antibodies in Dried Blood Spots accessed 14 September 2010. http://www.cdc.gov/labstandards/nsqap_reports.html.
17. Steel R.G.D., Torrie J.H. Principles and procedures of statistics 1980, McGraw-Hill Book Company, New York. second ed.
18. Ruxton G.D. The unequal variance t-test is an underused alternative to Student'st-test and the Mann-Whitney U test. Behav Ecol 2006, 17:688-690.
19. SAS Institute, Inc. Base SAS Procedures Guide. Version 9.2. ed. Carey NC: SAS Institute, Inc. 2008.
20. Collier S.A., Mei J.V., Li L.X., et al. Use of newborn dried blood spots to assess contribution of Toxoplasma gondii infection to etiology of hydrocephalus. Proceedings of the 2008 Newborn Screening and Genetics Testing Symposium, November 3-6, San Antonio, TX 2008.
21. Ruangturakit S., Rojanasuphat S., Srijuggravanvong A., Duangchonda S., Nuangplee S., Igarashi A. Storage stability of dengue IgM and IgG antibodies in whole blood and serum dried in filter paper strips detected by ELISA. Southeast Asian J Trop Med Public Health 1994, 25:560-564.
22. Chace D.H., Adam B.A., Smith S.J., Alexander R., Hillman S.L., Hannon W.H. Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays. Clin Chem 1999, 45:1269-1277.
23. Strnadova K.A., Holub M., Muhl A., et al. Long-term stability of amino acids and acylcarnitines in dried blood spots. Clin Chem 2007, 53:707-772.
24. Fingerhut R., Ensenauer R., Roschinger W., Arnecke R., Olgemoller B., Roscher A.A. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency. Anal Chem 2009, 81:3571-3575.
25. Lando V.S., Batista M.C., Nakamura I.T., Mazi C.R., Mendonca B.B., Brito V. Effects of long-term storage of filter paper blood samples on neonatal thyroid stimulating hormone, thyroxin and 17-alpha-hydroxyprogesterone measurements. J Med Screen 2008, 3:109-111.
26. Behets F., Kashamuka M., Pappaioanou M., et al. Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Micro 1992, 30:1179-1182.
27. Lebech M., Andersen O., Christensen N.C., et al. Feasibility of neonatal screening for toxoplasma infection in the absence of maternal treatment. Lancet 1999, 353:1834-1837.
28. Hannon WH, Whitley RJ, Davin B, et al. Blood collection on filter paper for newborn screening programs; approved standard-Fifth edition. Clinical Laboratory Standards Institute, LA5-A4, Wayne, PA: Clinical Laboratory Standard Institute, 2007.